AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Eriglim M 3mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Simpatico Healthcare

Salt Composition

Glimepiride (3mg) + Metformin (500mg)

Overview Eriglim M 3mg/500mg Tablet SR

Diabetace M, a 3mg/500mg extended-release tablet, is an antidiabetic medication combining two active components for adult type 2 diabetes management. This dual-action formulation helps regulate blood glucose. Diabetace M should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined individually by your physician and may adjust based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is part of a comprehensive diabetes management plan, including diet, exercise, and weight management as directed by your doctor. Lifestyle adjustments are vital for diabetes control. Hypoglycemia (low blood sugar) is the most frequent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are essential preventative measures. Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. Diabetace M is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your doctor before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring is necessary, and your physician may order blood tests to track blood cell counts and liver function.

Uses of Eriglim M 3mg/500mg Tablet SR

Managing Type 2 Diabetes

Major Benefits of Eriglim M 3mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Eriglim M 3mg/500mg Sustained-Release Tablets should be administered with a meal.

Common Side effects of Eriglim M 3mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Eriglim M 3mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Eriglim M 3mg/500mg Tablet SR whole; do not chew, crush, or fracture it. Administer this extended-release tablet with food.

How Eriglim M 3mg/500mg Tablet SR works:

Eriglim M SR tablets (3mg/500mg) combine the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Eriglim M 3mg/500mg SR tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Eriglim M 3mg/500mg tablet may pose risks during pregnancy. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

The extended-release Eriglim M 3mg/500mg tablet is contraindicated during lactation. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if these conditions arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Eriglim M 3mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician before use. This medication is contraindicated in individuals with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Eriglim M 3mg/500mg Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dose; the medication is unsuitable for patients with severe hepatic dysfunction.

What if you forget to take Eriglim M 3mg/500mg Tablet SR :

Should you forget to take your Eriglim M 3mg/500mg SR Tablet, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Eriglim M 3mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment

FAQs on Eriglim M 3mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Eriglim M 3mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Eriglim M 3mg/500mg Tablet SR and seek immediate medical attention.
Eriglim M 3mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is not suitable for type 1 diabetes.
Eriglim M 3mg/500mg Tablet SR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Eriglim M 3mg/500mg Tablet SR can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Eriglim M 3mg/500mg SR tablets can cause low blood sugar (hypoglycemia), characterized by symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Eriglim M 3mg/500mg SR tablets with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Eriglim M 3mg/500mg Table...
82
MRP 95
13% off